SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001660
Filing Date
2021-09-02
Accepted
2021-09-02 16:28:15
Documents
88
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20210630.htm   iXBRL 10-Q 2921602
2 EX-31.1 crbu-20210630ex31_1.htm EX-31.1 18236
3 EX-31.2 crbu-20210630ex31_2.htm EX-31.2 18230
4 EX-32.1 crbu-20210630ex32_1.htm EX-32.1 10782
5 EX-32.2 crbu-20210630ex32_2.htm EX-32.2 10771
  Complete submission text file 0000950170-21-001660.txt   11812998

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20210630.xsd EX-101.SCH 73275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20210630_pre.xml EX-101.PRE 459575
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20210630_cal.xml EX-101.CAL 50478
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20210630_lab.xml EX-101.LAB 573588
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20210630_def.xml EX-101.DEF 282485
11 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20210630_htm.xml XML 2560755
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 211233591
SIC: 2836 Biological Products, (No Diagnostic Substances)